Navigation Links
Diagnocure announces sponsorship of inaugural undy 5,000 run - Partnership with the Colon Cancer Alliance creates patient awareness of previstage(TM) GCC staging test
Date:9/11/2008

WEST CHESTER, PA, Sept. 11 /PRNewswire-FirstCall/ - DiagnoCure Oncology Laboratories, a subsidiary of DiagnoCure, announced corporate sponsorship of the Colon Cancer Alliance's (CCA) inaugural charity event the "Undy 5,000: A Brief Run to Fight Colon Cancer" being held in Philadelphia, PA, on September 27, 2008. The CCA is an advocacy group that focuses on the concerns of the colon cancer patient community. DiagnoCure will sponsor the race at the "Championship Level" to coincide with the CLIA certification of their molecular diagnostic laboratory and start of commercialization of the Company's Previstage(TM) GCC Colorectal Cancer Staging Test, which was announced recently.

"Through proactive outreach and creative events such as the Undy 5,000, we can educate patients about the importance of properly staging colorectal cancer and how Previstage(TM) GCC can help physicians and patients in making critical treatment decisions" stated John Schafer, President and CEO of DiagnoCure.

The American Cancer Society estimates there will be approximately 154,000 patients diagnosed with colorectal cancer in the U.S. each year. Colorectal cancer is the second leading cause of cancer death among men and women in the United States and Canada (after lung cancer). The Undy 5,000 salutes the brave men and women along with their families battling this disease.

"The CCA is very grateful to have DiagnoCure as a corporate sponsor. The Undy 5,000 is a great way for new and inventive technologies such as Previstage(TM) GCC to gain exposure with the colorectal cancer community" stated Tim Turnham, CEO Colon Cancer Alliance.

About Previstage(TM) GCC

Every year in North America, 174,000 people are diagnosed with colorectal cancer, and 142,000 colorectal cancer surgeries are performed. Staging a patient with colorectal cancer is crucial because it determines the patient's course of treatment after the surgery. Current standard of care requires that pathol
'/>"/>

SOURCE DIAGNOCURE INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. DiagnoCures GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group
2. DiagnoCure announces second quarter 2008 results
3. DiagnoCure to host Q2 2008 earnings conference call and webcast
4. DiagnoCures molecular diagnostic tests - PCA3 and GCC - discussed at scientific meetings
5. Council on Education in Management Announces New Commissioner Rod Bordelon will Present a Keynote Address at the 5th Annual Texas Workers' Comp Forum
6. U.S. Preventive Medicine Announces Nationwide Launch of The Prevention Plan
7. SSI Announces Agreement with Siemens Healthcare
8. Council on Education in Management Announces Insurance Commissioner Steve Poizner Will Present Keynote Address at the 6th Annual California Workers' Comp Forum
9. DSM Pharmaceutical Products Announces the Appointment of Thats Nice LLC as Agency of Record for Marketing
10. Governor Rendell Announces Resignation of Health Secretary Dr. Calvin Johnson
11. Transcend Medical Announces New President and CEO and Appointment of Chairman of the Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 Registration is now open ... Warriors® in Holmdel, New Jersey on Sunday, October 19, ... the New Jersey Vietnam Veterans’ Memorial adjacent to the ... Bank Arts Center. All proceeds of the event will ... to restoring a sense of self, restoring the family ...
(Date:8/28/2014)... 2014 An unprecedented service that finds local ... 9 Spine offers their resources online and in person. ... a brick wall of discouragement as activities and hobbies are ... Cloud 9 Spine offers a refreshing plan of action. ... interaction that sets Cloud 9 Spine apart from other service ...
(Date:8/28/2014)... Alpine, NJ resident Othon Mourkakos is proud to ... Tiaras, to benefit the Immune Deficiency Foundation (IDF) Walk ... in Foley Square, New York. IDF is the ... (PI) are a group of more than 200 rare, ... immune system is missing or functions improperly. In ...
(Date:8/28/2014)... IL (PRWEB) August 28, 2014 The ... the healthcare industry from the time a patient books ... and insurance company provide final payments for services rendered ... based medical billing service has the RCM process ... software programs and computers become common place in nearly ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 Aeroflow ... to acquire as part of a strategic expansion ... is positioned for taking ownership of new businesses ... increase economies of scale. , Last week, the ... with Hometown Respiratory to increase service in the ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors Announces Second Annual NJ Run 2Health News:Making Waves on the East Coast, Cloud 9 Spine is Helping Patients Find Appointments With Local Spine Doctors 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 3Health News:Aeroflow Healthcare Seeks Strategic Acquisition Opportunities 2
... able to stop or even slightly improve the progression ... to implant // embryonic cells into their brains, say ... that helps control movement. People with Parkinson’s don’t produce ... in people with the condition. ,Researchers compared 20 ...
... of Pittsburgh Medical Center treated 33 prostate cancer patients, ... Patients received the same radiation doses that patients in ... study show the elderly patients had a five-year survival ... patients experienced no unusual or prolonged breaks in treatment ...
... to cancer-causing pollutants found in the air, report researchers ... .Past studies in mice have shown exposure to pollutants ... the fact the placenta filters out most of the ... in humans. ,Researchers collected blood samples from 265 ...
... United States suffer from erectile dysfunction. This causes a ... and weight loss // , obese men with erectile ... say researchers. ,Researchers, conducted a study to determine ... increase in physical activity, would improve obese men’s erectile ...
... not decrease, but may increase, the risk for dementia ... an association between postmenopausal estrogen use and lower risk ... estrogen plus progestin in women aged 65 to 79 ... estrogen-only trial, researchers found 47 participants were diagnosed with ...
... 20s could reduce the risk of developing high blood pressure ... with spikes in blood pressure are more likely to have ... ,Specialists say assessing blood pressure changes in response to stress ... risk of high blood pressure. In a large study more ...
Cached Medicine News:
(Date:8/27/2014)... MENLO PARK, Calif. , Aug. 27, 2014 ... developer of advanced cancer therapeutics , will be featured ... & Renshaw Global Investment Conference, sponsored by H.C. ... Tuesday, September 9th at 2:55 p.m. EDT in the ... Palace Hotel in New York City ...
(Date:8/27/2014)...  Decision Resources Group finds that physicians surveyed ... gastroenterology, endocrinology and nephrology) expect the robustness and ... been assessed in to be the strongest influencers ... Other key findings from the ... of Biosimilars Across Physician Specialties : ...
(Date:8/27/2014)... ISPE , the International Society for ... preview of its Drug Shortages Prevention Plan ... and maintain a robust and reliable supply of medications ... first for the industry, was developed by ISPE and ... how industry can best prevent drug shortages from occurring ...
Breaking Medicine Technology:DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2ISPE Releases First Look at its Plan to Prevent Drug Shortages 2ISPE Releases First Look at its Plan to Prevent Drug Shortages 3ISPE Releases First Look at its Plan to Prevent Drug Shortages 4
... Va., April 16 Insmed Inc. (Nasdaq:,INSM), a ... it has received approval from the United Kingdom,s ... the Company,s,first clinical study for a follow-on biologic ... form of human G-CSF, is a follow-on,biologic of ...
... Activity in a Variety of Tumor Types, ... ENMD ), a clinical-stage pharmaceutical company developing,therapeutics for ... the presentation of preclinical results for two of ... given by EntreMed,scientists during two poster sessions at ...
Cached Medicine Technology:Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 2Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 4EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting 2EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting 3
Patient-Centered Therapy that promotes natural cardiac function....
The ACP 215 is the automated closed system cell processor with integrated process control....
... Durability for Excellent Access. Access ... challenging cases. PT² wires combine ... linear elastic nitinol distal core ... tip. This provides excellent access ...
... The PCS2 system ... for the collection of ... allow for the collection ... platelet-poor plasma, platelet-poor plasma ...
Medicine Products: